Cell Transfection Market Report 2026

Cell Transfection Market Overview

• Cell Transfection market size has reached to $1.42 billion in 2025 • Expected to grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Impact Of Rising Infectious Diseases On The Cell Transfection Market • Market Trend: Technological Innovations In Cell Transfection Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Transfection Market?

Cell transfection is a process used in molecular biology to introduce nucleic acids (such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or oligonucleotides) into eukaryotic cells. The method allows researchers to study gene function, protein expression, and various cellular processes by manipulating the genetic content of the cells. It is a crucial tool in genetic engineering, drug discovery and various fields of biomedical research. The main cell transfection methods are electroporation, lipofection, calcium phosphate, viral transfection, and others. Electroporation is a cell transfection method that uses brief electrical pulses to create temporary pores in cell membranes, allowing genetic material or molecules to enter the cell. It is applied for biomedical research, therapeutic delivery, and protein production by various end users, such as academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and others.

What Is The Cell Transfection Market Growth Forecast?

The cell transfection market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing development of gene and cell therapies, rising investments in genetic engineering research, growing demand for high-throughput screening assays, expansion of personalized medicine research, increasing use of non-viral delivery technologies. Major trends in the forecast period include increasing adoption of high-efficiency transfection reagents, rising use of viral vector-based transfection, growing demand for scalable transfection methods, expansion of automated transfection platforms, enhanced focus on transfection reproducibility.

Global Cell Transfection Market Segmentation

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods 2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production 3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users Subsegments: 1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation 2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection 3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods 4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction 5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

What Is The Driver Of The Cell Transfection Market?

The increase in the number of cases of infectious disease is expected to propel the growth of the cell transfection market going forward. Infectious diseases are illnesses caused by germs that spread from one person to another or through contaminated sources. Inadequate public health infrastructure, coupled with vaccine hesitancy and misinformation, has facilitated the spread and evolution of pathogens. Cell transfection is a powerful tool for infectious diseases because it allows scientists to insert genes into cells to study how infections affect them and to test new treatments. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from about 7.5 million in 2022, placing tuberculosis as the leading infectious disease killer. Therefore, the increase in the number of cases of infectious diseases drives the cell transfection industry.

Key Players In The Global Cell Transfection Market

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Global Cell Transfection Market Trends and Insights

Major companies operating in the cell transfection market are integrating innovations into transfection systems to enable precise control over gene expression. A transfection system is a technique or technology designed to introduce foreign nucleic acids into cells to study gene function, produce proteins, or alter gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched the Cellpore transfection system. It is a novel tool designed to enhance cell engineering research. This system employs advanced microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, addressing limitations associated with traditional transfection methods. It can transfect up to 10 million cells per second, making it suitable for large-scale applications. The system is compatible with various cell types, including T cells and hematopoietic stem cells. It can deliver diverse cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

What Are Latest Mergers And Acquisitions In The Cell Transfection Market?

In July 2023, Sartorius AG, a Germany-based pharmaceutical and laboratory equipment provider, acquired Polyplus-Transfection SA for $2.6 billion (€2.4 billion). The acquisition will strategically position Sartorius and Polyplus as key players in the dynamic cell and gene therapies field, leveraging Sartorius's expertise and Polyplus's innovative upstream market leadership. Polyplus-Transfection SA is a France-based provider of cell transfection solutions.

Regional Outlook

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Transfection Market?

The cell transfection market consists of revenues earned by entities by providing services such as stable cell line development, high-throughput transfection, transient transfection services and viral vector production. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell transfection market also includes sales of reagents, kits, electroporation systems and other related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Transfection Market Report 2026?

The cell transfection market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell transfection industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.